Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study

INTRODUCTION: Once-weekly (OW) semaglutide was associated with clinically relevant improvements in glycaemic control and body weight versus comparators in the SUSTAIN randomised controlled trials (RCTs). SURE UK, which is one of a series of individual studies that comprise the SURE programme, evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, Patrick, Bell, Heather Elizabeth, Bozkurt, Karan, Catarig, Andrei-Mircea, Clark, Alice, Machell, Alena, Sathyapalan, Thozhukat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475854/
https://www.ncbi.nlm.nih.gov/pubmed/34562237
http://dx.doi.org/10.1007/s13300-021-01141-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475854/
https://www.ncbi.nlm.nih.gov/pubmed/34562237
http://dx.doi.org/10.1007/s13300-021-01141-8

Ejemplares similares